Food and Drug Administration (FDA) postmarket reported side effects and adverse events associated with pulmonary hypertension therapy in pediatric patients.
about
Drug treatment of pulmonary hypertension in childrenSildenafil for the treatment of pulmonary hypertension in children.Treating pulmonary hypertension in pediatrics.Risk-benefit considerations when prescribing phosphodiesterase-5 inhibitors in children.Pharmacodynamic considerations in the treatment of pulmonary hypertension in infants: challenges and future perspectives.Dose-dependent effects of glucocorticoids on pulmonary vascular development in a murine model of hyperoxic lung injury.Development of a UPLC-MS/MS method for the quantification of sildenafil by DBS, and its use on pediatric pulmonary hypertension.Reported sildenafil side effects in pediatric pulmonary hypertension patients.PedAM: a database for Pediatric Disease Annotation and Medicine.
P2860
Q26996078-18D5986E-DDA0-4B65-90D2-DCDE3EEF34A9Q38249704-572201C6-C0D1-4EB9-9FBC-04E37B73B60BQ38349395-64ACAE5B-8E59-46F1-B27B-712195CE70AEQ38368957-D5CB2136-CBE6-4877-96D3-612039788E72Q38630552-ABB361B5-D34C-4B71-A8AA-441D21681728Q40881072-C6F4A2FF-800C-45C8-A8AC-65CC7E426128Q41716331-5D5D927C-EE2B-4531-8BD6-10916726FA33Q41900777-E3B5A28C-EB0C-4E6C-B514-009CFBB197CFQ47118733-3FD2F865-86DC-4C88-9C95-FB0348F3CD58
P2860
Food and Drug Administration (FDA) postmarket reported side effects and adverse events associated with pulmonary hypertension therapy in pediatric patients.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 27 March 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Food and Drug Administration ( ...... therapy in pediatric patients.
@en
Food and Drug Administration
@nl
type
label
Food and Drug Administration ( ...... therapy in pediatric patients.
@en
Food and Drug Administration
@nl
prefLabel
Food and Drug Administration ( ...... therapy in pediatric patients.
@en
Food and Drug Administration
@nl
P2093
P2860
P1433
P1476
Food and Drug Administration ( ...... therapy in pediatric patients
@en
P2093
D Dunbar Ivy
Dawn M Maxey
Michelle T Ogawa
P2860
P2888
P304
P356
10.1007/S00246-013-0688-2
P577
2013-03-27T00:00:00Z